Stocks-NKTR-Nektar Therapeutics

NKTR Nektar Therapeutics

3.09 0.09 (3.00%)
Delayed Prices By NASDAQ, in USD Market Closed
Invest
Invest
26.34% Past Week
Created with Highcharts 4.2.7 /Highstock 4.2.7
Market Cap
580.78M
Day’s Range
2.86
-
3.12
52W Range
1.97
-
11.57
Volume (3M)
1.66M
Price-Earnings Ratio
-
Revenue
95.04M

Nektar Therapeutics Latest News

View All
Pinned Post
eToro Team
🎉 Here’s a little preview introducing 16 YEARS of INVESTING on eToro 😏🤑 With love, - The eToro Team youtu.be/UFYvpJxh2qA
Like CommentShare
Show more comments2 of 63
null
.
Top Discussions

About Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company with operations primarily within the US and India. It researches and develops drug candidates for auto-immune diseases and cancer. Founded in 1990, Nektar Therapeutics has headquarters in San Francisco, California. It is listed under the NKTR ticker on the NASDAQ GS stock market. Easily follow the NKTR stock by making it an entry on your eToro watchlist.
740
Employees
San Francisco, California, US
HQ
1990
Founded
Howard W. Robin
CEO
Show More

Upcoming Earnings

27
FEB
REPORTS
Nektar Therapeutics Q4 2022 earnings report is expected to be released after market open

ESG: A New Source of Insight

Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
45
Low
Industry 
Avg. 47 
35
Environment
52
Social
45
Governance

People Also Bought